By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
China ObserverChina Observer
Notification
Latest News
Pakistan launches alliance to protect crypto users
November 10, 2026
China-Pakistan Information Corridor launched to strengthen media ties
October 28, 2026
Yasukuni Shrine visits and offerings tear away Japan’s “country for peace” mask
October 27, 2026
To reduce global poverty, the world should partner with China, not exclude it: Insights from a Fellow of British Academy of Social Sciences
October 27, 2026
China issues first policy document dedicated to technology-driven commerce
October 27, 2026
Aa
  • Home
  • Pakistan
  • China
  • Sports
  • World
  • Business
  • Technology
  • Entertainment
  • Tourism
  • Videos
  • Health
  • More
    • Articles
    • Currency Rates
    • Gold Rates
    • Daily Horoscope
Reading: Turning immune cells into cancer’s worst enemy: China’s CAR-T revolution
Share
Aa
China ObserverChina Observer
  • Home
  • Pakistan
  • China
  • Sports
  • World
  • Business
  • Technology
  • Entertainment
  • Tourism
  • Videos
  • Health
  • More
Search
  • Home
  • Pakistan
  • China
  • Sports
  • World
  • Business
  • Technology
  • Entertainment
  • Tourism
  • Videos
  • Health
  • More
    • Articles
    • Currency Rates
    • Gold Rates
    • Daily Horoscope
Have an existing account? Sign In
Follow US
China Observer > Blog > China > Turning immune cells into cancer’s worst enemy: China’s CAR-T revolution
ChinaTechnology

Turning immune cells into cancer’s worst enemy: China’s CAR-T revolution

April 24, 2025 4 Min Read
Updated 24/04/25 at 2:40 PM
Share
4 Min Read
A researcher with JW Therapeutics conducts analytical work using precision instruments. (File photo)

By Ji Juesu, People’s Daily

In early March 2024, Mr. Zhou, a 63-year-old resident of Shanghai, returned to a hospital for what would become his third fight against diffuse large B-cell lymphoma. But this time, he was not relying on the chemotherapy and targeted therapy that had defined his previous treatments. Instead, he placed his hopes in a new frontier of precision treatment: CAR-T cell therapy.

Short for chimeric antigen receptor-T cell therapy, CAR-T is a rapidly evolving form of immunotherapy that reimagines cancer treatment – not by attacking tumors directly, but by supercharging the body’s own immune defenses.

At the heart of this approach are T cells – the immune system’s frontline soldiers. These white blood cells spring into action when the body encounters infections or tumors, working to defend against threats. CAR-T therapy takes that natural defense and amplifies it, genetically reprogramming the T cells into precision-targeting cancer killers. The secret lies in the “CAR,” or chimeric antigen receptor – a custom-built molecule added to the T cells that enables them to recognize and lock onto cancer cells with uncanny accuracy.

In Zhou’s case, his blood was drawn and sent to a manufacturing facility operated by JW Therapeutics in Suzhou, east China’s Jiangsu province. There, his T cells underwent a series of complex steps designed to turn them into cancer-fighting powerhouses.

The process began with isolating and cryopreserving the T cells at temperatures below minus 130 degrees Celsius to preserve their original activity. When ready, the frozen cells were thawed and genetically modified using a viral vector that introduced the CAR – a molecular homing device for cancer. But a single engineered cell isn’t enough. These modified cells were expanded into bioreactors to create an army of at least 100 million. After rigorous purification, concentration, and quality control, Zhou’s customized therapy was complete and ready for delivery.

Three weeks later, he received a call: the infusion was ready. Transported under strict temperature control, the CAR-T cells were thawed and delivered back into Zhou’s bloodstream.

The results were almost immediate. Zhou developed a mild fever – a common side effect of the immune response triggered by the therapy – and soon noticed his swollen lymph nodes shrinking. A month later, follow-up scans brought good news: complete remission. The engineered T cells had not only cleared cancer, but were now standing sentry within his immume system, guarding against its return.

“We’re continuing to push our research forward so more patients can access and benefit from this treatment,” said Xia Zhen, executive director of clinical development at JW Therapeutics.

Globally, more than a dozen CAR-T therapies have received regulatory approval. In patients with relapsed or refractory large B-cell lymphoma, responses rate hover around 80 percent. Of those, 40 percent to 60 percent have gone on to survive five years or more – offering real hope for a potential cure.

Shanghai, meanwhile, is positioning itself as a hub for next-generation biotechnologies. With supportive policies and investment in life sciences, the city is unlocking innovation in cell therapy and aims to make breakthroughs like CAR-T more accessible to the patients who need them most.

You Might Also Like

China-Pakistan Information Corridor launched to strengthen media ties

To reduce global poverty, the world should partner with China, not exclude it: Insights from a Fellow of British Academy of Social Sciences

China issues first policy document dedicated to technology-driven commerce

Grassland city in N China’s Inner Mongolia transforms into an AI computing hub

A conversation with Liu Cixin: From The Three-Body Problem to the future of humanity

Top Categories

admin April 24, 2025
Share this Article
Facebook Twitter Whatsapp Whatsapp LinkedIn Email Print
Leave a comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Follow US

Find US on Social Medias
Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe
Corporate

Pakistan launches alliance to protect crypto users

China

China-Pakistan Information Corridor launched to strengthen media ties

Articles

Yasukuni Shrine visits and offerings tear away Japan’s “country for peace” mask

China

To reduce global poverty, the world should partner with China, not exclude it: Insights from a Fellow of British Academy of Social Sciences

BusinessTechnology

China issues first policy document dedicated to technology-driven commerce

About Us

We influence 20 million users and is the number one business and technology news network on the planet.

You Might Also Like

China

China-Pakistan Information Corridor launched to strengthen media ties

October 28, 2026
China

To reduce global poverty, the world should partner with China, not exclude it: Insights from a Fellow of British Academy of Social Sciences

October 27, 2026
BusinessTechnology

China issues first policy document dedicated to technology-driven commerce

October 27, 2026
Technology

Grassland city in N China’s Inner Mongolia transforms into an AI computing hub

October 27, 2026
logo-chinaoberver-tranparent-small

About US

We influence 20 million users and is the number one business and technology news network on the planet.
  • Contact
  • Blog
  • Complaint
  • Advertise
Menu
  • Contact
  • Blog
  • Complaint
  • Advertise

Market Performers

Subscribe US

Weather Widgets for Websites

©China observer. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?